Dr. Jing Zhong joined CASH Capital in 2018 as an investment manager, covering innovative medicine and biotech, IVD molecular diagnostics and medical devices. He had years of experience in Molecular diagnostics and RNAi, and experience in healthcare investment in China and U.S. Previously he worked with Starting Gate Partners LLC. and BGI Genomics, where he led investments in Wegene, Genewell, Nanjing Zhimao. Dr. Jing Zhong holds a B.A in biotech from Wuhan University, Ph.D in Cell and Molecular Biology from University of California, Riverside, and MBA from UNC Kenan-Flagler Business School. He is a mentor at Tsinghua SEM X-elerator, member of ASV, GSA societies, and Shenzhen Yantian Phoenix Tree Talent.